Brenda M. Maloney Shafer

Publications and Presentations

Newsletter
Michael FrenchMichael French
340B Program Changes on the Horizon? Start Planning Now for Potentially Seismic Impact of Upcoming Genesis DecisionHealth & Life SciencesMichael French, Brenda Maloney Shafer, Richard B. Davis, Madison T. HartmanAs the extensively covered Genesis Healthcare, Inc. v. Azar case continues to proceed, 340B covered entities expect to soon receive much-anticipated clarification on what can reasonably constitute a 340B eligible patient. In the meantime, covered entities should begin planning and... Read More
Presentation "2022 Pharmacy Law Symposium" Quarles & Brady Seminar Brenda Maloney Shafer, Christopher T. Dang, Roger N. Morris, Theodore M. Sullivan, Kirti Vaidya Reddy, Mark W. Bina, Edward D. Rickert, Nicholas H. Meza, John E. Hintz, Ryan L. Torres, Richard B. Davis, Michael French, Katea M. Ravega, Anne M. O'Brien, Laura Tepich MacDonald, Elizabeth R. Gebarski, Amy Cotton Peterson, Susan Brichler Trujillo
"The 340B Drug Pricing Program Year in Review: What's Smoke and What's Fire in a Changing Landscape" Quarles & Brady Pharmacy Law Symposium
Payment Portal

You are leaving the Quarles & Brady website and being directed to the bill presentment and paying service offered by a third party provider. If you do not wish to continue to the site, click Close or use the Back button on your web browser to return the Quarles & Brady website.